Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Rossi

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2000
Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNAA Michienzi, L Cagnon, I Bahner, et al.
AIDS Research and Human Retroviruses|February 1, 1992
Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problemsJ J Rossi, D Elkins, J A Zaia, et al.
Antisense & Nucleic Acid Drug Development|January 26, 1999
Unusual interactions between cleavage products of a cis-cleaving hammerhead ribozymeD Castanotto, W A Chow, H Li, et al.
Gene|March 21, 1995
Ribozymes expressed within the loop of a natural antisense RNA form functional transcription terminatorsJ O Deshler, H Li, J J Rossi, et al.
DNA (Mary Ann Liebert, Inc.)|October 1, 1987
Enzymatic synthesis of oligoribonucleotides of defined sequenceK Ebe, M Schöld, J J Rossi, et al.
Canadian Journal of Microbiology|March 1, 1987
Oligonucleotide probes for the detection of TEM-1 and TEM-2 beta-lactamase genes and their transposonsM Ouellette, J J Rossi, R Bazin, et al.
Antisense Research and Development|January 1, 1993
Ribozymes: use as anti-HIV therapeutic moleculesB Dropulic, D A Elkins, J J Rossi, et al.
Gene|April 1, 1983
Saccharomyces cerevisiae actin--Escherichia coli lacZ gene fusions: synthetic-oligonucleotide-mediated deletion of the 309 base pair intervening sequence in the actin geneG P Larson, K Itakura, H Ito, et al.
Antisense & Nucleic Acid Drug Development|January 1, 1996
Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibitionC Zhou, I Bahner, J J Rossi, et al.
Pharmacology & Therapeutics|January 1, 1991
The potential use of catalytic RNAs in therapy of HIV infection and other diseasesJ J Rossi, E M Cantin, N Sarver, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2000
Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNAA Michienzi, L Cagnon, I Bahner, et al.
AIDS Research and Human Retroviruses|February 1, 1992
Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problemsJ J Rossi, D Elkins, J A Zaia, et al.
Antisense & Nucleic Acid Drug Development|January 26, 1999
Unusual interactions between cleavage products of a cis-cleaving hammerhead ribozymeD Castanotto, W A Chow, H Li, et al.
Gene|March 21, 1995
Ribozymes expressed within the loop of a natural antisense RNA form functional transcription terminatorsJ O Deshler, H Li, J J Rossi, et al.
DNA (Mary Ann Liebert, Inc.)|October 1, 1987
Enzymatic synthesis of oligoribonucleotides of defined sequenceK Ebe, M Schöld, J J Rossi, et al.
Canadian Journal of Microbiology|March 1, 1987
Oligonucleotide probes for the detection of TEM-1 and TEM-2 beta-lactamase genes and their transposonsM Ouellette, J J Rossi, R Bazin, et al.
Antisense Research and Development|January 1, 1993
Ribozymes: use as anti-HIV therapeutic moleculesB Dropulic, D A Elkins, J J Rossi, et al.
Gene|April 1, 1983
Saccharomyces cerevisiae actin--Escherichia coli lacZ gene fusions: synthetic-oligonucleotide-mediated deletion of the 309 base pair intervening sequence in the actin geneG P Larson, K Itakura, H Ito, et al.
Antisense & Nucleic Acid Drug Development|January 1, 1996
Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibitionC Zhou, I Bahner, J J Rossi, et al.
Pharmacology & Therapeutics|January 1, 1991
The potential use of catalytic RNAs in therapy of HIV infection and other diseasesJ J Rossi, E M Cantin, N Sarver, et al.
Pageof 13